Richard C Gregory

Title: Profile of Inventor Richard C. Gregory

Introduction

Richard C. Gregory, based in Framingham, MA, is a distinguished inventor known for his significant contributions to the field of biopharmaceuticals. With a total of four patents to his name, his innovative work focuses on the development of therapeutic antibodies used in the treatment of various medical conditions.

Latest Patents

Among his notable inventions are the patents related to Anti-TGF-beta antibodies and their use. This invention presents an advanced pan-TGF-β antibody that aims to treat conditions mediated by TGF-β, which includes autoimmune diseases, fibrotic conditions, and cancers. The patent also outlines methods and uses of this antibody when used in combination with other immunomodulatory agents, such as an anti-PD-1 antibody. This breakthrough offers new avenues for treating patients suffering from complex immune-related conditions.

Career Highlights

Throughout his career, Richard has made significant impacts while working at notable companies like Sanofi and Genzyme Corporation. His expertise in the biopharmaceutical industry has enabled him to contribute to innovative solutions and therapies that address critical medical needs.

Collaborations

Richard has worked with esteemed colleagues such as Gary Shapiro and Kevin Brower. These collaborations have played a vital role in enhancing the quality and reach of his inventions, fostering an environment of shared knowledge and experience in their projects.

Conclusion

In conclusion, Richard C. Gregory's innovative work in the field of Anti-TGF-beta antibodies marks him as a noteworthy inventor. With multiple patents that hold the potential to revolutionize treatments for various diseases, his career continues to inspire upcoming inventors in the biopharmaceutical sector. His contributions not only enhance therapeutic possibilities but also significantly influence future research and development in the medical field.